TIPS of the Tehran University of Medical Sciences

The Institute of Pharmaceutical Sciences (TIPS) is a new name for Pharmaceutical Sciences Research Center (PSRC) which was officially launched from February 2018. Drug Design and Development Research Center, and Pharmaceutics Quality Assurance Research Center are two joint centers of TIPS. TIPS tries to spread interest in research among students, to recruit and support researchers at all academic levels, to conduct both fundamental and applied ...

Read more »

Latest News   Archive

...

بازدید نماینده و عضو کمیسیون صنایع و معادن مجلس از پژوهشکده علوم دارویی

مهندس منصوری نماینده شهرستان ساوه و عضو کمیسیون صنایع و معادن مجلس در راستای ارتباط دانشگاه با صنعت و جامعه از پژوهشکده علوم دارویی بازدید به عمل آورد.
...

Defence meeting of Mehdi Mogharrabi, PhD student of TIPS

On 16 February 2019, Mehdi Mogharrabi, TIPS's PhD student of Pharmaceutical Sciences did his thesis final defense during a meeting in front of the internal and external referees.
...

برگزاری آخرین جلسات شورای محیطی ارتباط با صنعت، شورای علمی، و کمیته اخلاق سازمانی سال 97 در پژوهشکده علوم دارویی

پژوهشکده علوم دارویی میزبان برگزاری جلسات شورای محیطی ارتباط با صنعت، شورای علمی، و کمیته اخلاق سازمانی در تاریخ 5 اسفند 97 بود.
...

دانشجوی بین الملل پژوهشکده علوم دارویی برگزیده پنجمین جشنواره دانشجویی ابن سینا

فضل الله خان دانشجوی دکترای تخصصی پژوهشکده علوم دارویی به عنوان برگزیده بخش دانشجویی جامع بین الملل در پنجمین جشنواره دانشجویی ابن سینا در سال 97 معرفی شد.

Journal Clubs

  • ...

    How to look at your manuscripts through the eyes of a reviewer?

    At TIPS journal club meeting held on March 04, 2019, the topic of “How to look at your manuscripts through the eyes of a reviewer?” was presented by Dr. M. Daghighi. A brief summary of this presentation is in below. Reviewers see whether the paper is within the scope of the journal, whether the science is good, and whether the paper meets the conceptual novelty standards of the journal. At a manuscript text level, one of the reviewer's priorities is to check the article's internal consistency. By that, it means that do the method and results match? Do the results and conclusion match? A common weakness is that the different sections appear to have been written independently of each other. If the paper is cohesive it is elevated to a whole new level. Other items are that they concentrate on the writing and presentation. The science might be great, but heavy composition and messy structure might bog down the main message. The reviewers may suggest to the authors how to make the story more cohesive and tightly reasoned.

  • ...

    Startup companies: from formation to success

    At TIPS journal club meeting held on March 11, 2019, TIPS invited guest gave a presentation about “Startup companies: from formation to success”. At this session of the TIPS journal club meeting Dr. R. Fazel, director of Livogen Pharmed company gave a lecture about building a startup. He presented his company as a successful knowledgebase startup specialized in the field of Biotechnology. He explained that the company is committed to delivering high quality services and offering a wide range of off-the-shell and customized assays for biopharmaceutical-producing cell line characterization and protein characterization, as well as genetic stability and safety assessments of cell banks to biopharmaceutical and biotechnology industries, and research institutes. Then, he explained about important steps can be taken to achieved a successful startup.

  • ...

    Block buster drugs 2018

    At the TIPS journal club meeting held on April 08, 2019, a topic of “Block buster drugs 2018’’ was presented by R. Farhadi. A brief summary of this presentation is in below. 2018 is set to be an exciting year that will see valuable additions to existing treatments as well as disruptions to certain markets. By 2022, three drugs are forecast to exceed annual revenue of more than $3 billion, while nine additional drugs are forecast to generate annual sales of between $1 billion and $2 billion. As the drug-pricing debate continues in 2017 a record of 46 new drug approvals by the Food and Drug Administration (FDA) is published which is the highest total in more than two decades. Of these approved drugs, 17 (37%) were approved with breakthrough therapy designation, a designation created in 2012 to accelerate the development of products that showed substantial improvement over existing therapies for serious and life-threatening diseases. The approval of cancer immunotherapies) and chimeric antigen receptor T cell (CAR-T) therapies grabbed headlines in 2017 because of their ability to revolutionize the treatment of the disease. These therapies, a form of gene therapy, represent a major breakthrough for the development of personalized medicine and lay the groundwork for further advances in this field.

  • ...

    Predicting Alzheimer's Disease using Machine Learning

    At the TIPS journal club meeting held on April 15, 2019, a topic on “Predicting Alzheimer's Disease using Machine Learning’’ was presented by M. AlJasem, MD-MPH student. A brief summary of this presentation is in below. In this session we have walked through the history of artificial intelligence and how it evolved to be a cornerstone of many of the services we are using in our daily life although these application were considered to be science fiction few decades ago. Then we have discussed the best ways to start a career in the field of artificial intelligence. Before diving into the main topic , a short review of the pathophysiology of Alzheimer's Disease was presented for the audiences. In the last part of this session , Project ENZAIR was introduced, and the way it works to make early prediction on the probability of getting Alzheimer's Disease just by feeding it a MRI scan and some other information such as gender and and educational level. The presentation was followed by warm discussion in which the presenter answered the questions of the attendees.